Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Istituto di Ematologia di Bologna · Sapienza University of Rome · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
820
total citations
- FWCI
- 40.91
- Percentile
- 100%
- References
- 40
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Medicine
- Bortezomib
- Multiple myeloma
- Thalidomide
- Dexamethasone
- Autologous stem-cell transplantation
- Regimen
- Transplantation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.